Literature DB >> 7832923

Non-progression in HIV infection.

P J Easterbrook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7832923     DOI： 10.1097/00002030-199408000-00023

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  13 in total

1.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.

Authors:  Chanelle J Howe; Stephen R Cole; Joan S Chmiel; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2011-02-02       Impact factor: 4.897

3.  The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

Authors:  G Pantaleo; J F Demarest; T Schacker; M Vaccarezza; O J Cohen; M Daucher; C Graziosi; S S Schnittman; T C Quinn; G M Shaw; L Perrin; G Tambussi; A Lazzarin; R P Sekaly; H Soudeyns; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.

Authors:  M Shi; J M Taylor; J L Fahey; D R Hoover; A Muñoz; L A Kingsley
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

5.  Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.

Authors:  O J Cohen; M Vaccarezza; G K Lam; B F Baird; K Wildt; P M Murphy; P A Zimmerman; T B Nutman; C H Fox; S Hoover; J Adelsberger; M Baseler; J Arthos; R T Davey; R L Dewar; J Metcalf; D J Schwartzentruber; J M Orenstein; S Buchbinder; A J Saah; R Detels; J Phair; C Rinaldo; J B Margolick; G Pantaleo; A S Fauci
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Authors:  Elena Priceputu; Zaher Hanna; Chunyan Hu; Marie-Chantal Simard; Patrick Vincent; Steffen Wildum; Michael Schindler; Frank Kirchhoff; Paul Jolicoeur
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

7.  Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.

Authors:  E Barker; C E Mackewicz; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Low relative frequencies of CD26(+) CD4(+) cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects.

Authors:  C Broström; A Sönnerborg; S Lindbäck; H Gaines
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.

Authors:  I Stefanová; M W Saville; C Peters; F R Cleghorn; D Schwartz; D J Venzon; K J Weinhold; N Jack; C Bartholomew; W A Blattner; R Yarchoan; J B Bolen; I D Horak
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 10.  HIV preventive vaccines. Progress to date.

Authors:  J Esparza; S Osmanov; W L Heyward
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.